Empagliflozin + Metformin is a prescription tablet that joins two diabetes medicines, empagliflozin and metformin (often listed as metformin hydrochloride or metformin HCl), in one pill. It is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. The twice-daily tablet is also approved for children aged 10 years and older. Empagliflozin helps the kidneys pass extra sugar out in the urine. Metformin lowers the sugar made by the liver and helps the body respond better to insulin. The empagliflozin part may also lower the risk of heart-related death and heart failure hospital stays in certain adults. Empagliflozin + Metformin is not used for type 1 diabetes.
Empagliflozin + Metformin brings together two medicines that lower blood sugar in different ways. Having both in one tablet means fewer pills to keep track of for people who need both.
The first ingredient, empagliflozin, belongs to a group called SGLT2 inhibitors. It works in the kidneys. Normally the kidneys pull sugar back out of the urine and return it to the blood. Empagliflozin blocks this, so extra sugar leaves the body in the urine. The second ingredient, metformin, belongs to a group called biguanides. It lowers the amount of sugar the liver makes, reduces the sugar the gut absorbs from food, and helps the body use its own insulin better.
Empagliflozin + Metformin is used with a healthy diet and regular exercise to improve blood sugar control in adults with type 2 diabetes. The twice-daily tablet is also approved for children aged 10 years and older. The empagliflozin in it can also lower the risk of death from heart disease and of hospital stays for heart failure in certain adults. On its own, empagliflozin is also used to lower the risk of kidney disease getting worse, hospital stays for heart failure, and death in certain adults with kidney disease. It helps control diabetes as a long-term treatment, and it is not meant for type 1 diabetes.
The medicine comes in two forms. The regular tablet is usually taken twice a day with meals. The extended-release (XR) tablet releases the medicine slowly and is usually taken once a day with the morning meal.
Empagliflozin + Metformin needs regular medical supervision. Its label carries a boxed warning for a rare but life-threatening problem caused by metformin, called lactic acidosis. The risk is higher with kidney problems, age 65 or older, liver problems, heavy drinking, surgery, and scans that use contrast dye. Your doctor will check how well your kidneys work before and during treatment. You will also have regular blood sugar and HbA1c tests (a blood test that shows your average sugar level over time). The label advises checking vitamin B12 levels every 2 to 3 years, because metformin can lower vitamin B12.
Common Side Effects (Usually Mild and may lessen with continued use)
Serious Side Effects (Seek Urgent Medical Attention)
Empagliflozin + Metformin lowers blood sugar through two separate actions that support each other.
Empagliflozin (SGLT2 inhibitor). The kidneys filter the blood all day. As they do, a transporter called SGLT2 (sodium-glucose co-transporter 2) acts like a pump that pulls sugar back from the filtered fluid into the blood. SGLT2 is the main pump that does this job. Empagliflozin blocks it. As a result, more sugar leaves the body in the urine, and blood sugar comes down. Empagliflozin also reduces how much salt (sodium) the kidneys take back. This action also explains the extra urination, thirst, and positive urine sugar tests that some people notice.
Metformin (biguanide). Metformin works mainly on the liver, the gut, and the body's response to insulin. The liver makes and releases sugar into the blood, and metformin lowers this. It also reduces the amount of sugar absorbed from food in the gut. Finally, it improves insulin sensitivity, meaning the body's own insulin works better at moving sugar out of the blood and into the cells.
Working together. One medicine removes extra sugar through the kidneys, while the other cuts the sugar entering the blood from the liver and gut. The two parts act at different places in the body, so each covers a different source of high blood sugar.
Do not take Empagliflozin + Metformin if you are allergic to empagliflozin, metformin, or any of the ingredients in the tablet. Get emergency medical help right away if you have signs of a serious allergic reaction, such as rash, hives, itching, swelling of the face, lips, tongue or throat, hoarseness, or trouble breathing or swallowing.
The label does not recommend Empagliflozin + Metformin during the second and third trimesters of pregnancy, and the patient guide says it may harm an unborn baby. Tell your doctor if you are pregnant or planning a pregnancy, and call your doctor if you become pregnant while taking it.
Not recommended. Do not breastfeed while taking Empagliflozin + Metformin.
Avoid drinking alcohol often or drinking a lot in a short time (binge drinking). Alcohol raises the risk of lactic acidosis and can change blood sugar levels.
Empagliflozin + Metformin can cause dizziness or light-headedness, and low blood sugar can occur, mainly with insulin or sulfonylureas. Avoid driving if you feel dizzy, shaky, or confused.
Must not be used in severe kidney disease (eGFR, a blood-test measure of how well your kidneys filter the blood, below 30). Starting it is not recommended when eGFR is below 45. Your doctor will check kidney function before and during treatment.
Not recommended in people with liver problems, because liver disease raises the risk of lactic acidosis.
The twice-daily tablet is approved for children aged 10 years and older with type 2 diabetes. The XR tablet is approved for adults only.
People aged 65 or older have a higher risk of lactic acidosis and dehydration. Doctors check kidney function more often in older adults.
Stop taking Empagliflozin + Metformin and get medical help right away if you notice:
Therapeutic Class
Antidiabetic (blood sugar lowering)
Action Class
SGLT2 (sodium-glucose co-transporter 2) inhibitor + biguanide
Chemical Class
Glucitol derivative (empagliflozin) + biguanide (metformin)
Habit Forming
No
Checkout Editorial Policy
Empagliflozin 12.5mg + Metformin 1000mg

₹164.1

₹225
MRP ₹450
Empagliflozin 12.5mg + Metformin 500mg

₹90.9

₹94.5
MRP ₹189
Empagliflozin 12.5mg + Metformin 500mg

₹425

₹94.5
MRP ₹189
Empagliflozin 12.5mg + Metformin 1000mg

₹225
MRP ₹450
Empagliflozin 10mg + Metformin 1000mg

₹97.6
MRP ₹119
Empagliflozin 12.5mg + Metformin 500mg

₹120.9

₹94.5
MRP ₹189
Empagliflozin 12.5mg + Metformin 500mg

₹167.8

₹94.5
MRP ₹189
Empagliflozin 25mg + Metformin 1000mg

₹164.1

₹122.5
MRP ₹245
Empagliflozin 25mg + Metformin 1000mg

₹122.5
MRP ₹245
Empagliflozin 5mg + Metformin 1000mg

₹58.6
MRP ₹117.2
Empagliflozin 12.5mg + Metformin 500mg

₹190.1

₹94.5
MRP ₹189
Empagliflozin 5mg + Metformin 500mg

₹168.8

₹57.5
MRP ₹115
Empagliflozin 12.5mg + Metformin 500mg

₹154.7

₹94.5
MRP ₹189
Empagliflozin 5mg + Metformin 500mg

₹98.4

₹57.5
MRP ₹115
Empagliflozin 12.5mg + Metformin 500mg

₹178.1

₹94.5
MRP ₹189
Empagliflozin 5mg + Metformin 500mg

₹206.3

₹57.5
MRP ₹115
Empagliflozin 12.5mg + Metformin 1000mg

₹126.6

₹225
MRP ₹450
Empagliflozin 5mg + Metformin 500mg

₹168.8

₹57.5
MRP ₹115
Empagliflozin 12.5mg + Metformin 1000mg

₹445.3

₹225
MRP ₹450
Empagliflozin 12.5mg + Metformin 500mg

₹125.6

₹94.5
MRP ₹189
Empagliflozin 5mg + Metformin 500mg

₹111.6

₹57.5
MRP ₹115
Empagliflozin 12.5mg + Metformin 1000mg

₹176.3

₹225
MRP ₹450
Empagliflozin 12.5mg + Metformin 500mg

₹103.1

₹94.5
MRP ₹189
Empagliflozin 12.5mg + Metformin 1000mg

₹139.7

₹225
MRP ₹450
Empagliflozin 12.5mg + Metformin 500mg

₹130.3

₹94.5
MRP ₹189